(Total Views: 1408)
Posted On: 03/31/2017 2:15:04 AM
Post# of 11802
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
"The company’s capacity for
GenUltimate! production is now 625,000 packages per month (50 count and 100 count packages), for the new GenSure! product
250,000 packages per month (25 count and 50 count packages) and the new GenChoice! product 400,000 packages per month (50
count and 100 count packages). Recently, a mega- retailer has requested minimum inventories of finished product of 350,000."
Quote:
The company’s second international agreement is through a South American financier who has
businesses in Bolivia and Spain. This group has placed orders for approximately $17 million in GenUltimate! product, GenUltimate!
meters and the company’s new (2017) Firefly! Lancets. Almost 11,000 pieces (units) of GenUltiomate!, 3,000 GenUltimate! meters
and cases of lancets have been delivered to Bolivia. In addition, the South America financier has funded the company’s regulatory
applications (through a Spanish pharmaceutical company) with the EU, to gain “CE” marking for its GenUltimate! and GenSure!
products in return for the Spanish distribution rights to these two products. And lastly, the South American financier has notified the
company that he and those closely associated with him wished to subscribe to a $3.25 million to $5.0 million capital investment in the
company.
Ramping up capacities, delivering products, partnering people and companies. DECN is clearlly moving forward.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)